Journal of Endocrinological Investigation

, Volume 33, Issue 4, pp 266–275 | Cite as

Secretin: Should we revisit its metabolic outcomes?

  • D. H. St-Pierre
  • F. Broglio
Review Article


Metabolic pathologies such as Type 2 Diabetes have become a major health problem for worldwide populations. Unfortunately, efforts to cure and especially to prevent these significant global problems have so far been met with disappointment. Recently, the involvement of the gut-derived hormonal dysregulation in the development of obesity-related disturbances has been intensively studied. For instance, studies of gut-derived peptides such as peptide YY 3-36, glucagon-like peptide-1, oxyntomodulin and, more recently, ghrelin have significantly improved our understanding of mechanisms underlying weight and metabolic regulation. Even though early reports of the existence of secretin, the first peptide hormone to be described, date back as far as 1825, so much and yet so little is still known about its physiological role in mammals, including humans. However, recent years have provided a better understanding of how the release of secretin is regulated by enteral secretagogues. On the other hand, most basic questions about its role in the post-prandial regulation of metabolic functions in normal and pathophysiological conditions remain to be elucidated. The present work intends to review the physiology of secretin along with its central and peripheral outcomes on metabolic functions.

Key Words

Glucose insulin metabolism peripheral effects secretin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gardiner JV, Jayasena CN, Bloom SR. Gut hormones: a weight off your mind. J Neuroendocrinol 2008, 20: 834–41.PubMedGoogle Scholar
  2. 2.
    ChiRhoClin I. Label — Human Secretin. Burtonsville, MD: ChiRhoClin, Inc. 2004, 13.Google Scholar
  3. 3.
    Malone RP, Gratz SS, Delaney MA, Hyman SB. Advances in drug treatments for children and adolescents with autism and other pervasive developmental disorders. CNS Drug 2005, 19: 923–34.Google Scholar
  4. 4.
    Bayliss WM, Starling EH. On the causation of the so-called “peripheral reflex secretion” of the pancreas. Proc Royal Soc 1902, 69: 352–3.Google Scholar
  5. 5.
    Bayliss WM, Starling EH. The mechanism of pancreatic secretion. J Physiol 1902, 28: 325–53.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Starling EH. The Croonian Lecture on the chemical correlation of the functions of the body IV. Lancet 1905, 166: 579–83.Google Scholar
  7. 7.
    Starling EH. The Croonian Lecture on the chemical correlation of the functions of the body II. Lancet 1905, 166: 423–5.Google Scholar
  8. 8.
    Starling EH. The Croonian Lecture on the chemical correlation of the functions of the body I. Lancet 1905, 166: 339–41.Google Scholar
  9. 9.
    Starling EH. The Croonian Lecture on the chemical correlation of the functions of the body III. Lancet 1905, 166: 501–3.Google Scholar
  10. 10.
    La Barre J. Sur les possibilités d’un traitement du diabète par l’incrétine. Bull Acad R Méd Belg 1932, 12: 620–34.Google Scholar
  11. 11.
    Jorpes E, Mutt V. On the biological activity and amino acid composition of secretin. Acta Chem Scand 1961, 15: 1790–1.Google Scholar
  12. 12.
    Mutt V, Jorpes JE, Magnusson S. Structure of porcine secretin. The amino acid sequence. Eur J Biochem 1970, 15: 513–9.PubMedGoogle Scholar
  13. 13.
    Bodanszky M, Ondetti MA, Levine SD, et al. Synthesis of a heptacosapeptide amide with the hormonal activity of sccretin. Chem Ind 1966, 42: 1757–8.PubMedGoogle Scholar
  14. 14.
    Itoh N, Furuya T, Ozaki K, Ohta M, Kawasaki T. The secretin precursor gene. Structure of the coding region and expression in the brain. J Biol Chem 1991, 266: 12595–8.PubMedGoogle Scholar
  15. 15.
    Gafvelin G, Jörnvall H, Mutt V. Processing of prosecretin: isolation of a secretin precursor from porcine intestine. Proc Natl Acad Sci USA 1990, 87: 6781–5.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Kopin AS, Wheeler MB, Leiter AB. Secretin: structure of the precursor and tissue distribution of the mRNA. Proc Natl Acad Sci U S A 1990, 87: 2299–303.PubMedCentralPubMedGoogle Scholar
  17. 17.
    Ohta M, Funakoshi S, Kawasaki T, Itoh N. Tissue-specific expression of the rat secretin precursor gene. Biochem Biophys Res Commun 1992, 183: 390–5.PubMedGoogle Scholar
  18. 18.
    Whitmore TE, Holloway JL, Lofton-Day CE, et al. Human secretin (SCT): gene structure, chromosome location and distrbution of mRNA. Cytogenet Cell Genet 2000, 90: 47–52.PubMedGoogle Scholar
  19. 19.
    Chey WY, Chang CH, Pan HJ, et al. Evidence on the presence of secretin cells in the gastric antral and oxyntic mucosa. Regul Pept 2003, 111: 183–90.PubMedGoogle Scholar
  20. 20.
    Banks WA, Goulet M, Rusche JR, Niehoff ML, Boismenu R. Differential transport of a secretin analog across the blood-brain and blood cerebrospinal fluid barriers of the mouse. J Pharmacol Exp Ther 2002, 302: 1062–9.PubMedGoogle Scholar
  21. 21.
    Dupre J. An intestinal hormone affecting glucose disposal in man. Lancet 1964, 2: 672–3.PubMedGoogle Scholar
  22. 22.
    Young JD, Lazarus L, Chisholm DJ, Atkinson FF. Radioimmunoassay of secretin in human serum. J Nucl Med 1968, 9: 641–2.PubMedGoogle Scholar
  23. 23.
    Chisholm DJ, Young JD, Lazarus L. The gastrointestinal stimulus to insulin release. I. Secretin. J Clin Invest 1969, 48: 1453–60.Google Scholar
  24. 24.
    Green GM, Taguchi S, Friestman J, Chey WY, Liddle RA. Plasma secretin, CCK, and pancreatic secretion in response to dietary fat in the rat. Am J Physiol 1989, 256: G1016–21.PubMedGoogle Scholar
  25. 25.
    Shiratori K, Watanabe S, Takeuchi T. Effect of licorice extract (Fm100) on release of secretin and exocrine pancreatic secretion in humans. Pancreas 1986, 1: 483–7.PubMedGoogle Scholar
  26. 26.
    Chey WY, Chang TM. Secretin, 100 years later. J Gastroenterol 2003, 38: 1025–35.PubMedGoogle Scholar
  27. 27.
    Chang TM, Lee KY, Chang CH, et al. Purification of two secretin-releasing peptides structurally related to phospholipase A2 from canine pancreatic juice. Pancreas 1999, 19: 401–5.PubMedGoogle Scholar
  28. 28.
    Lee ST, Lee KY, Li P, et al. Pituitary adenylate cyclase-activating peptide stimulates rat pancreatic secretion via secretin and chole-cystokinin releases. Gastroenterology 1998, 114: 1054–60.PubMedGoogle Scholar
  29. 29.
    Li JP, Chang TM, Chey WY. Roles of 5-HT receptors in the release and action of secretin on pancreatic secretion in rats. Am J Physiol Gastrointest Liver Physiol 2001, 280: G595–602.PubMedGoogle Scholar
  30. 30.
    Park HS, Kwon HY, Lee YL, Chey WY, Park HJ. Role of GRPergic neurons in secretin-evoked exocrine secretion in isolated rat pancreas. Am J Physiol Gastrointest Liver Physiol 2000, 278: G557–62.PubMedGoogle Scholar
  31. 31.
    Brodows RG, Chey WY. Physiological doses of secretin do not stimulate acute insulin release. J Clin Endocrinol Metab 1980, 50: 603–6.PubMedGoogle Scholar
  32. 32.
    Fahrenkrug J, Schaffalitzky de Muckadell OB, Kuhl C. Effect of secretin on basal- and glucose-stimulated insulin secretion in man. Diabetologia 1978, 14: 229–34.PubMedGoogle Scholar
  33. 33.
    Leuret F, Lassaigne J. Recherches physiologiques et chimiques pour servir à l’histoire de la digestion. Paris: Madame Huzard, 1825.Google Scholar
  34. 34.
    Beglinger C, Gyr K, Werth B, Keller U, Girard J. Comparative effects of synthetic and natural secretin on pancreatic secretion and on secretin, insulin, and glucagon levels in man. Dig Dis Sci 1982, 27: 231–3.PubMedGoogle Scholar
  35. 35.
    Schaffalitzky de Muckadell OB, Fahrenkrug J, Watt-Boolsen S, Worning H. Pancreatic response and plasma secretin concentration during infusion of low dose secretin in man. Scand J Gastroenterol 1978, 13: 305–11.PubMedGoogle Scholar
  36. 36.
    Stengel A, Keire D, Goebel M, et al. The RAPID method for blood processing yields new insight in plasma concentrations and molecular forms of circulating gut peptides. Endocrinology 2009, 150: 5113–8.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Trimble ER, Bruzzone R, Biden TJ, Farese RV. Secretin induces rapid increases in inositol trisphosphate, cytosolic Ca2+ and diacylglycerol as well as cyclic AMP in rat pancreatic acini. Biochem J 1986, 239: 257–61.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Ohara H, Inabe S, Yabu-uchi S, Ohta H, Wada T. Secretin secretion in patients with duodenal ulcer, chronic pancreatitis and diabetes mellitus. Gastroenterol Jpn 1978, 13: 21–7.PubMedGoogle Scholar
  39. 39.
    Draviam EJ, Gomez G, Hashimoto T, et al. Characterization of secretin release in response to food and intraduodenal administration of fat and hydrochloric acid. Dig Dis Sci 1991, 36: 513–9.PubMedGoogle Scholar
  40. 40.
    Robberecht P, Waelbroeck M, Noyer M, et al. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides secretin-(7–27) and five secretin analogues. Digestion 1982, 23: 201–10.PubMedGoogle Scholar
  41. 41.
    Gespach C, Bataille D, Vauclin N, Rosselin G, Moroder L, Wünsch E. Secretin binding sites coupled with adenylate cyclase in rat fundic membranes. Peptides 1981, 2: 247–51.PubMedGoogle Scholar
  42. 42.
    Roth BL, Beinfeld MC, Howlett AC. Secretin receptors on neuroblatoma cell membranes: characterization of 125I-labeled secretin binding and association with adenylate cycalse. J Neurochem 1984, 42: 1145–52.PubMedGoogle Scholar
  43. 43.
    Bissonnette BM, Collen MJ, Adachi H, Jensen RT, Gardner JD. Receptors for vasoactive intestinal peptide and secretin on rat pancreatic acini. Am J Physiol 1984, 246: G710–7.PubMedGoogle Scholar
  44. 44.
    Bawab W, Gespach C, Marie JC, Chastre E, Rosselin G. Pharmacology and molecular identification of secretin receptors in rat gastric glands. Life Sci 1988, 42: 791–8.PubMedGoogle Scholar
  45. 45.
    Gossen D, Poloczek P, Svoboda M, Christophe J. Molecular architecture of secretin receptors: the specific covalent labelling of a 51 kDa peptide after cross-linking of [125I]iodosecretin to intact pancreatic acini. FEBS Lett 1989, 243: 205–8.PubMedGoogle Scholar
  46. 46.
    Couvineau A, Voisin T, Guijarro L, Laburthe M. Purification of vasoactive intestinal peptide receptor from porcine liver by a newly designed one-step affinity chromatography. J Biol Chem 1990, 265: 13386–90.PubMedGoogle Scholar
  47. 47.
    Solomon TE, Varga G, Zeng N, Wu SV, Walsh JH, Reeve JR Jr. Different actions of secretin and Gly-extended secretin predict secretin receptor subtypes. Am J Physiol Gastrointest Liver Physiol 2001, 280: G88–94.PubMedGoogle Scholar
  48. 48.
    Ishihara T, Nakamura S, Kaziro Y, et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J 1991, 10: 1635–41.PubMedCentralPubMedGoogle Scholar
  49. 49.
    Jiang S, Ulrich C. Molecular cloning and functional expression of a human pancreatic secretin receptor. Biochem Biophys Res Commun 1995, 207: 883–90.PubMedGoogle Scholar
  50. 50.
    Chow BK. Molecular cloning and functional characterization of a human secretin receptor. Biochem Biophys Res Commun 1995, 212: 204–11.PubMedGoogle Scholar
  51. 51.
    Ho PK, Fong RS, Kai HS, et al. The human secretin receptor gene: genomic organization and promoter characterization. FEBS Lett 1999, 455: 209–14.PubMedGoogle Scholar
  52. 52.
    Vilardaga JP, Di Paolo E, Bialek C, et al. Mutational analysis of extracellular cysteine residues of rat secretin receptor shows that disulfide bridges are essential for receptor function. Eur J Biochem 1997, 246: 173–80.PubMedGoogle Scholar
  53. 53.
    Di Paolo E, Petry H, Moguilevsky N, et al. Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor. Receptors Channels 1999, 6: 309–15.PubMedGoogle Scholar
  54. 54.
    Di Paolo E, De Neef P, Moguilevsky N, et al. Contribution of the second transmembrane helix of the secretin receptor to the positioning of secretin. FEBS Lett 1998, 424: 207–10.PubMedGoogle Scholar
  55. 55.
    Izzo RS, Chen AI, Pellecchia C, Praissman M. Secretin internalization and adenosine 3′,5′-monophosphate levels in pancreatic acinar cells. Endocrinology 1989, 124: 2252–60.PubMedGoogle Scholar
  56. 56.
    Walker JK, Premont RT, Barak LS, Caron MG, Shetzline MA. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor. J Biol Chem 1999, 274: 31515–23.PubMedGoogle Scholar
  57. 57.
    Bawab W, Chastre E, Gespach C. Functional and structural characterization of the secretin receptors in rat gastric glands: desensitization and glycoprotein nature. Biosci Rep 1991, 11: 33–42.PubMedGoogle Scholar
  58. 58.
    Pang RT, Ng SS, Cheng CH, Holtmann MH, Miller LJ, Chow BK. Role of N-linked glycosylation on the function and expression of the human secretin receptor. Endocrinology 1999, 140: 5102–11.PubMedGoogle Scholar
  59. 59.
    Williams JA. Regulatory mechanisms in pancreas and salivary acini. Annu Rev Physiol 1984, 46: 361–75.PubMedGoogle Scholar
  60. 60.
    Trimble ER, Bruzzone R, Biden TJ, et al. Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. Proc Natl Acad Sci U S A 1987, 84: 3146–50.PubMedCentralPubMedGoogle Scholar
  61. 61.
    Kwon HY, Chang TM, Lee KY, Chey WY. Vagus nerve modulates secretin binding sites in the rat forestomach. Am J Physiol 1999, 276: G1052–8.PubMedGoogle Scholar
  62. 62.
    Chneiweiss H, Glowinski J, Premont J. Do secretin and vasoactive intestinal peptide have independent receptors on striatal neurons and glial cells in primary cultures? J Neurochem 1986, 47: 608–13.PubMedGoogle Scholar
  63. 63.
    Tang C, Biemond I, Offerhaus GJ, Verspaget W, Lamers CB. Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. Br J Cancer 1997, 75: 1467–73.PubMedCentralPubMedGoogle Scholar
  64. 64.
    Tang C, Biemond I, Lamers CB. Expression of peptide receptors in human endocrine tumours of the pancreas. Gut 1997, 40: 267–71.PubMedCentralPubMedGoogle Scholar
  65. 65.
    Ulrich CD 2nd, Wood P, Hadac EM, Kopras E, Whitcomb DC, Miller LJ. Cellular distribution of secretin receptor in rat pancreas. Am J Physiol 1998, 275: G1437–44.PubMedGoogle Scholar
  66. 66.
    Körner M, Hayes GM, Rehmann R, et al. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Am J Pathol 2005, 167: 959–68.PubMedCentralPubMedGoogle Scholar
  67. 67.
    Robberecht P, De Neef P, Waelbroeck M, et al. Secretin receptors in human pancreatic membranes. Pancreas 1988, 3: 529–35.PubMedGoogle Scholar
  68. 68.
    Raeder MG. The origin of and subcellular mechanisms causing pancreatic bicarbonate secretion. Gastroenterology 1992, 103: 1674–84.PubMedGoogle Scholar
  69. 69.
    Jyotheeswaran S, Li P, Chang TM, Chey WY. Endogenous nitric oxide mediates pancreatic exocrine secretion stimulated by secretin and cholecystokinin in rats. Pancreas 2000, 20: 401–7.PubMedGoogle Scholar
  70. 70.
    Gray MA, Greenwell JR, Argent BE. Secretin-regulated chloride channel on the apical plasma membrane of pancreatic duct cells. J Membr Biol 1988, 105: 131–42.PubMedGoogle Scholar
  71. 71.
    Ishiguro H, Steward MC, Lindsay AR, Case RM. Accumulation of intracellular HCO3- by Na(+)-HCO3-cotransport in interlobular ducts from guinea-pig pancreas. J Physiol 1996, 495 (Pt 1): 169–78.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Chey WY, Chang TM. Neural control of the release and action of secretin. J Physiol Pharmacol 2003, 54 (Suppl 4): 105–12.PubMedGoogle Scholar
  73. 73.
    Steiner TS, Mangel AW, McVey DC, Vigna SR. Secretin receptors mediating rat forestomach relaxation. Am J Physiol 1993, 264: G863–7.PubMedGoogle Scholar
  74. 74.
    SutliffV E, Raufman JP, Jensen RT, Gardner JD. Actions of vasoactive intestinal peptide and secretin on chief cells prepared from guinea pig stomach. Am J Physiol 1986, 251: G96–102.Google Scholar
  75. 75.
    Tani S, Suzuki T, Kano S, et al. Mechanisms of gastric mucus secretion from cultured rat gastric epithelial cells induced by carbachol, cholecystokinin octapeptide, secretin, and prostaglandin E2. Biol Pharm Bull 2002, 25: 14–8.PubMedGoogle Scholar
  76. 76.
    Gespach C, Bataille D, Dupont C, Rosselin G, Wünsch E, Jaeger E. Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum. Biochim Biophys Acta 1980, 630: 433–41.PubMedGoogle Scholar
  77. 77.
    Buchan AM, Meloche RM, Kwok YN, Kofod H. Effect of cholecystokinin and secretin on somatostatin release from cultured antral cells. Gastroenterology 1993, 104: 1414–9.PubMedGoogle Scholar
  78. 78.
    Gespach C, Bataille D, Vauclin N, Moroder L, Wünsch E, Rosselin G. Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacology. Peptides 1986, 7 (Suppl 1): 155–63.PubMedGoogle Scholar
  79. 79.
    Lu Y, Owyang C. Secretin at physiological doses inhibits gastric motility via a vagal afferent pathway. Am J Physiol 1995, 268: G1012–6.PubMedGoogle Scholar
  80. 80.
    Stening GF, Johnson LR, Grossman MI. Effect of secretin on acid and pepsin secretion in cat and dog. Gastroenterology 1969, 56: 468–75.PubMedGoogle Scholar
  81. 81.
    Wormsley KG, Grossman MI. Inhibition of gastric acid secretion by secretin and by endogenous acid in the duodenum. Gastroenterology 1964, 47: 72–81.PubMedGoogle Scholar
  82. 82.
    Chey WY, Kim MS, Lee KY, Chang TM. Secretin is an enterogastrone in the dog. Am J Physiol 1981, 240: G239–44.PubMedGoogle Scholar
  83. 83.
    Li P, Chang TM, Chey WY. Secretin inhibits gastric acid secretion via a vagal afferent pathway in rats. Am J Physiol 1998, 275: G22–8.PubMedGoogle Scholar
  84. 84.
    Hicks T, Turnberg LA. The influence of secretin on ion transport in the human jejunum. Gut 1973, 14: 485–90.PubMedCentralPubMedGoogle Scholar
  85. 85.
    Hirose S, Shimazaki K, Hattori N. Effect of secretin and caerulein on the absorption of water, electrolytes and glucose from the jejunum of dogs. Digestion 1986, 35: 205–10.PubMedGoogle Scholar
  86. 86.
    Liu P, Li WP, Machleidt T, Anderson RG. Identification of caveolin-1 in lipoprotein particles secreted by exocrine cells. Nat Cell Biol 1999, 1: 369–75.PubMedGoogle Scholar
  87. 87.
    Isenberg JI, Wallin B, Johansson C, et al. Secretin, VIP, and PHI stimulate rat proximal duodenal surface epithelial bicarbonate secretion in vivo. Regul Pept 1984, 8: 315–20.PubMedGoogle Scholar
  88. 88.
    Reimer R, Odes HS, Beil W, et al. Bicarbonate secretion in the guinea pig duodenum: functional characterization of peptide hormone receptors in duodenal enterocytes. Pharmacology 1996, 52: 339–46.PubMedGoogle Scholar
  89. 89.
    Olsen PS, Kirkegaard P, Poulsen SS, Nexo E. Effect of secretin and somatostatin on secretion of epidermal growth factor from Brunner’s glands in the rat. Dig Dis Sci 1994, 39: 21 86–90.Google Scholar
  90. 90.
    Wang JY, McCormack SA, Viar MJ, Johnson LR. Secretin inhibits induction of ornithine decarboxylase activity by gastrin in duodenal mucosa and IEC-6 cells. Am J Physiol 1994, 267: G276–84.PubMedGoogle Scholar
  91. 91.
    Siu FK, Sham MH, Chow BK. The prenatal expression of secretin receptor. Ann N Y Acad Sci 2006, 1070: 561–5.PubMedGoogle Scholar
  92. 92.
    Hubel KA. Secretin: a long progress note. Gastroenterology 1972, 62: 318–41.PubMedGoogle Scholar
  93. 93.
    Alpini G, Lenzi R, Sarkozi L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988, 81: 569–78.Google Scholar
  94. 94.
    Alpini G, Ulrich CD, 2nd, Phillips JO, et al. Upregulation of secretin receptor gene expression in rat cholangiocytes after bile duct ligation. Am J Physiol 1994, 266: G922–8.PubMedGoogle Scholar
  95. 95.
    Körner M, Hayes GM, Rehmann R, et al. Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. J Hepatol 2006, 45: 825–35.PubMedGoogle Scholar
  96. 96.
    Tiaho F, Nerbonne JM. VIP and secretin augment cardiac L-type calcium channel currents in isolated adult rat ventricular myocytes. Pflugers Arch 1996, 432: 821–30.PubMedGoogle Scholar
  97. 97.
    Gunnes P, Smiseth OA, Lygren I, Jorde R. Effects of secretin infusion on myocardial performance and metabolism in the dog. J Cardiovasc Pharmacol 1985, 7: 1183–7.PubMedGoogle Scholar
  98. 98.
    Chiba S. Effect of secretin on pacemaker activity and contractility in the isolated blood-perfused atrium of the dog. Clin Exp Pharmacol Physiol 1976, 3: 167–72.PubMedGoogle Scholar
  99. 99.
    Christophe J, Waelbroeck M, Chatelain P, Robberecht P. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology. Peptides 1984, 5: 341–53.Google Scholar
  100. 100.
    Chatelain P, Robberecht P, Camus JC, et al. The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors. Eur J Pharmacol 1983, 93: 271–6.PubMedGoogle Scholar
  101. 101.
    Robberecht P, De Neef P, Camus JC, et al. The cardiac inotropic response to secretin is lower in genetically obese (fa/fa) than in lean (fa/?) Zucker rats. Pflugers Arch 1983, 398: 217–20.PubMedGoogle Scholar
  102. 102.
    De Fontaine S, Robberecht P, De Neef P, Christophe J. Alteration of secretin-stimulated cardiac adenylate cyclase activity in rats with portacaval shunt. Peptides 1986, 7: 645–9.PubMedGoogle Scholar
  103. 103.
    Gunnes P, Rasmussen K. Haemodynamic effects of pharmacological doses of secretin in patients with impaired left ventricular function. Eur Heart J 1986, 7: 146–9.PubMedGoogle Scholar
  104. 104.
    Gunnes P, Reikeras O. Distribution of the increased cardiac output secondary to the vasodilating and inotropic effects of secretin. Scand J Clin Lab Invest 1987, 47: 383–8.PubMedGoogle Scholar
  105. 105.
    Gunnes P, Reikerås O. Peripheral distribution of the increased cardiac output by secretin during acute ischemic left ventricular failure. J Pharmacol Exp Ther 1988, 244: 1057–61.PubMedGoogle Scholar
  106. 106.
    Davis RJ, Page KJ, Dos Santos Cruz GJ, et al. Expression and functions of the duodenal peptide secretin and its receptor in human lung. Am J Respir Cell Mol Biol 2004, 31: 302–8.PubMedGoogle Scholar
  107. 107.
    Körner MU, Hayes GM, Carrigan PE, Rehmann R, Miller LJ, Reubi JC. Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid turmors and peritumoral lung tissue. Mod Pathol 2008, 21: 387–95.PubMedGoogle Scholar
  108. 108.
    Charlton CG, Quirion R, Handelmann GE, et al. Secretin receptors in the rat kidney: adenylate cyclase activation and renal effects. Peptides 1986, 7: 865–71.PubMedGoogle Scholar
  109. 109.
    Chu JY, Chung SC, Lam AK, Tam S, Chung SK, Chow BK. Phenotypes developed in secretin receptor-null mice indicated a role for secretin in regulating renal water reabsorption. Mol Cell Biol 2007, 27: 2499–511.PubMedCentralPubMedGoogle Scholar
  110. 110.
    Rudman D, Del Rio AE. Lipolytic activity of synthetic porcine secretin. Endocrinology 1969, 85: 214–7.PubMedGoogle Scholar
  111. 111.
    Rodbell M, Birnbaumer L, Pohl SL. Adenyl cyclase in fat cells. 3. Stimulation by secretin and the effects of trypsin on the receptors for lipolytic hormones. J Biol Chem 1970, 245: 718–22.PubMedGoogle Scholar
  112. 112.
    Moore B, Edie E, Abram J. On the treatment of diabetes mellitus by extract of duodenal mucous membrane. Biochem J 1906, 1: 28–38.PubMedCentralPubMedGoogle Scholar
  113. 113.
    Loew ER, Gray JS, Ivy AC. Is a duodenal hormone involved in carbohydrate metabolism? Amer J Physiol 1940, 129: 659–63.Google Scholar
  114. 114.
    Pfeiffer EF, Telib M, Ammon J, Melani F, Ditschuneit H. Direkte stimulierung der insulinesekretion in vitro durch sekretin. Dtsch Med Wochenschr 1965, 90: 1663–9.PubMedGoogle Scholar
  115. 115.
    Deckert T. Stimulation of insulin secretion by glucagon and secretin. Acta Endocrinol (Copenh) 1968, 57: 578–84.Google Scholar
  116. 116.
    Boyns DR, Jarrett RJ, Keen H. Intestinal hormones and plasma insulin: an insulinotropic action of secretin. Br Med J 1967, 2: 676–8.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Dupré J, Rojas L, White JJ, Unger RH, Beck JC. Effects of secretin on insulin and glucagon in portal and peripheral blood in man. Lancet 1966, 2: 26–7.PubMedGoogle Scholar
  118. 118.
    Unger RH, Ketterer H, Eisentraut A, Dupré J. Effect of secretin on insulin secretion. Lancet 1966, 2: 24–6.PubMedGoogle Scholar
  119. 119.
    Dupre J, Curtis JD, Unger RH, Waddell W, Beck JC. Effects of secretin, pancreozymin, or gastrin on the response of the endocrine pancreas to administration of glucose or arginine in man. J Clin Invest 1969, 48: 745–57.PubMedCentralPubMedGoogle Scholar
  120. 120.
    Lerner RL, Porte D, Jr. Studies of secretin-stimulated insulin responses in man. J Clin Invest 1972, 51: 2205–10.PubMedCentralPubMedGoogle Scholar
  121. 121.
    Enk B. Secretin-induced insulin response. II. Dose-response relation. Acta Endocrinol (Copenh) 1976, 82: 312–7.Google Scholar
  122. 122.
    Unger RH, Ketterer H, Dupre J, Eisentraut AM. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest 1967, 46: 630–45.PubMedCentralPubMedGoogle Scholar
  123. 123.
    Dupre J, Chisholm DJ, McDonald TJ, Rabinovitch A. Effects of secretin on insulin secretion and glucose tolerance. Can J Physiol Pharmacol 1975, 53: 1115–21.PubMedGoogle Scholar
  124. 124.
    Kraegen EW, Ghisholm DJ, Young DJ, Lazarus L. The gastrointestinal stimulus to insulin release. J Clin Invest 1970, 49: 524–9.PubMedCentralPubMedGoogle Scholar
  125. 125.
    Chey WY, Lee YH, Hendricks JG, Rhodes RA, Tai HH. Plasma secretin concentrations in fasting and postprandial state in man. Am J Digest Dis 1978, 23: 981–8.PubMedGoogle Scholar
  126. 126.
    Lerner RL. Augmented insulin responses to glucose after secretin priming in diabetic subjects. J Clin Endocrinol Metab 1979, 48: 462–6.PubMedGoogle Scholar
  127. 127.
    Glaser B, Shapiro B, Glowniak J, Fajans SS, Vinik AI. Effects of secretin on the normal and pathological beta-cell. J Clin Endocrinol Metab 1988, 66: 1138–43.PubMedGoogle Scholar
  128. 128.
    Santeusanio F, Faloona GR, Unger RH. Suppressive effect of secretin upon pancreatic alpha cell function. J Clin Invest 1972, 51: 1743–9.PubMedCentralPubMedGoogle Scholar
  129. 129.
    Bauer FE, Schulz E, Janisch HD, von Kleist D, Hampel KE. [Absence of effect of secretin and cholecystokinin on plasma concentrations of vasoactive intestinal polypeptide and pancreatic glucagon]. Wien Klin Wochenschr 1985, 97: 603–5.PubMedGoogle Scholar
  130. 130.
    Hisatomi A, Unger RH. Secretin inhibits glucagon in the isolated perfused dog pancreas. Diabetes 1983, 32: 970–3.PubMedGoogle Scholar
  131. 131.
    Propst F, Moroder L, Wunsch E, Hamprecht B. The influence of secretin, glucagon and other peptides, of amino acids, prostaglandin endoperoxide analogues and diazepam on the level of adenosine 3′,5′-cyclic monophosphate in neuroblastoma × glioma hybrid cells. J Neurochem 1979, 32: 1495–500.PubMedGoogle Scholar
  132. 132.
    Lee SM, Yung WH, Chen L, Chow BK. Expression and spatial distribution of secretin and secretin receptor in human cerebellum. Neuroreport 2005, 16: 219–22.PubMedGoogle Scholar
  133. 133.
    Yung WH, Leung PS, Ng SS, et al. Secretin facilitates GABA transmission in the cerebellum. J Neurosci 2001, 21: 7063–8.PubMedGoogle Scholar
  134. 134.
    Nozaki S, Nakata R, Mizuma H, et al. In vitro autoradiographic localization of (125)i-secretin receptor binding sites in rat brain. Biochem Biophys Res Commun 2002, 292: 133–7.PubMedGoogle Scholar
  135. 135.
    Tay J, Goulet M, Rusche J, Boismenu R. Age-related and regional differences in secretin and secretin receptor mRNA levels in the rat brain. Neurosci Lett 2004, 366: 176–81.PubMedGoogle Scholar
  136. 136.
    Yung WH, Chan YS, Chow BK, Wang JJ. The role of secretin in the cerebellum. Cerebellum 2006, 5: 43–8.PubMedGoogle Scholar
  137. 137.
    Karelson E, Laasik J, Sillard R. Regulation of adenylate cyclase by galanin, neuropeptide Y, secretin and vasoactive intestinal polypeptide in rat frontal cortex, hippocampus and hypothalamus. Neuropeptides 1995, 28: 21–8.PubMedGoogle Scholar
  138. 138.
    Kuntz A, Clement HW, Lehnert W, et al. Effects of secretin on extracellular amino acid concentrations in rat hippocampus. J Neural Transm 2004, 111: 931–9.PubMedGoogle Scholar
  139. 139.
    Fuxe K, Andersson K, Hökfelt T, et al. Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. Fed Proc 1979, 38: 2333–40.PubMedGoogle Scholar
  140. 140.
    Babu GN, Vijayan E. Plasma gonadotropin, prolactin levels and hypothalamic tyrosine hydroxylase activity following intraventricular bombesin and secretin in ovariectomized conscious rats. Brain Res Bull 1983, 11: 25–9.PubMedGoogle Scholar
  141. 141.
    Yang B, Goulet M, Boismenu R, Ferguson AV. Secretin depolarizes nucleus tractus solitarius neurons through activation of a non-selective cationic conductance. Am J Physiol Regul Integr Comp Physiol 2004, 286: R927–34.PubMedGoogle Scholar
  142. 142.
    Yang H, Wang L, Wu SV, et al. Peripheral secretin-induced Fos expression in the rat brain is largely vagal dependent. Neuroscience 2004, 128: 131–41.PubMedGoogle Scholar
  143. 143.
    Goulet M, Shiromani PJ, Ware CM, et al. A secretin i.v. infusion activates gene expression in the central amygdala of rats. Neuroscience 2003, 118: 881–8.PubMedGoogle Scholar
  144. 144.
    Grovum WL. Factors affecting the voluntary intake of food by sheep. 3. The effect of intravenous infusions of gastrin, cholecystokinin and secretin on motility of the reticulo-rumen and intake. Br J Nutr 1981, 45: 183–201.PubMedGoogle Scholar
  145. 145.
    Hashimoto R, Kimura F. The depressor effect of secretin administered either centrally or peripherally in conscious rats. Regul Pept 1987, 19: 233–42.PubMedGoogle Scholar
  146. 146.
    Conter RL, Hughes MT, Kauffman GL, Jr. Intracerebroventricular secretin enhances pancreatic volume and bicarbonate response in rats. Surgery 1996, 119: 208–13.PubMedGoogle Scholar
  147. 147.
    Charlton CG, Miller RL, Crawley JN, Handelmann GE, O’Donohue TL. Secretin modulation of behavioral and physiological functions in the rat. Peptides 1983, 4: 739–42.PubMedGoogle Scholar
  148. 148.
    Banks WA, Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S. Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann N Y Acad Sci 1996, 805: 270–7; discussion 7–9.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2010

Authors and Affiliations

  1. 1.Division of Endocrinology, Diabetology and Metabolism, Department of Internal Medicine, Ospedale MolinetteUniversity ofTurinItaly

Personalised recommendations